Cannabis and cannabinoids for people with multiple sclerosis

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess benefit and safety of cannabis‐based medicines, including synthetic, or herbal and plant‐derived cannabinoids, for people with MS.

Uloženo v:
Podrobná bibliografie
Vydáno v:Cochrane Database Syst Rev
Hlavní autoři: Filippini, Graziella, Lasserson, Toby J, Dwan, Kerry, D'Amico, Roberto, Borrelli, Francesca, Izzo, Angelo A, Minozzi, Silvia
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley & Sons, Ltd 2019
Témata:
Medicine General & Introductory Medical Sciences
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6797023/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD013444
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky